Why the study?
Platelets have received relatively less attention in pulmonary hypertension research despite associations with key pathophysiological processes and potential to identify new therapeutic strategies.
This review highlights the multifaceted role of platelets in the pathobiology of pulmonary hypertension, suggesting that platelet-associated pathways may offer new therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Platelets merit prioritized study in PH pathobiology; extends vascular-inflammatory models and leaves open targeted interventions.
Nicoleau et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: